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1. Introduction 
One of the most common problems in Regenerative Medicine is the regeneration of 
damaged bone with the aim of repairing or replacing lost or damaged bone tissue by 
stimulating the natural regenerative process. Particularly in the fields of orthopedic, plastic, 
reconstructive, maxillofacial and craniofacial surgery there is need for successful methods to 
restore bone. From a regenerative point of view two different bone replacement problems 
can be distinguished: large bone defects and small bone defects. Currently, no perfect 
system exists for the treatment of large bone defects. Autologous bone material from the hip 
or the split calvarial graft is the gold standard to repair bone defects, as it has osteoinductive 
and osteoconductive properties (Tessier, 1982; Tessier et al., 2005a; Laurencin et al., 2006). 
Unfortunately this method is associated with an additional invasive intervention that leads 
to an increase risk of infection, pain during recovery, morbidity and frequent long periods of 
convalescence due to surgical trauma. Besides, only a limited amount of tissue can be 
obtained and harvested (Younger & Chapman, 1989; Tessier et al., 2005b). Also, the outcome 
is not always satisfactory after surgical treatment using bone splits (Baltzer et al., 2000; 
Lietman et al., 2000; Sorger et al., 2001). Heterologous transplants on the other hand, bear 
the risk of infection and rejection of the donor material. If the required amount of implant 
material cannot be obtained, another source is bovine-derived xenografts. There is, however, 
a potential risk for prion infection that cannot be totally avoided. Last not least large bone 
defect replacement needs nutrient and oxygen supply via blood vessels, so angiogenesis 
must be considered. This is very different in small bone defects: here angiogenesis is not an 
issue, but most of the other problems addressed above do play a role here too. This chapter 
will focus on small bone defects, especially those linked to dental implants. 
2. Bone structure and regulation  
The skeletal system is composed of bones that support the body, protect internal organs, 
and allow movement. Bone itself can be described as a natural composite material that 
consists of minerals and collagen that are merged in a complex amalgam. It consists mainly 
of two structures: an organic component as a matrix that contains collagen and a mineral 
component that is predominantly hydroxyapatite (Rho et al., 1997). The complex mineral 
substances give hardness to the bone and the softer organic collagen matrix causes visco-
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elasticity and toughness (Hutmacher et al., 2007). Together with cartilage, connective tissue, 
nerves, blood vessels, and marrow, they constitute the bone. 
In the mineralized organic bone matrix, living and dead cells are present. Three types are 
known to play a role in bone homeostasis: osteoblasts, osteocytes and osteoclasts. 
Osteoblasts are derived from MSCs and are cuboidal in shape (Fig. 1). They contain 
prominent Golgi bodies with a well developed rough endoplasmic reticulum, which is a 
histological sign for prominent protein production. These cells are located on the 
endosteal and periosteal bone surfaces. They secrete collagen type I and the non-
collagenous proteins of the organic bone matrix. These cells also synthesize the enzyme 
alkaline phosphatase (ALP) that regulates the mineralization of the bone matrix. Their 
lifetime is about three months, after which they become metabolically inactive, flattened 
bone lining cells (Fig. 1). Bone lining cells are found covering inactive bone surfaces where 
they serve as a barrier for certain ions. The osteocytes originate from metabolically 
inactive osteoblasts and become trapped within the newly formed bone matrix during 
bone formation. Osteocytes have reduced synthetic activity compared to osteoblasts but 
maintain their sensitivity to vitamin D while continuing to participate in calcium 
regulation. On the other hand osteoclasts are derived from the fusion of monocyte and 
macrophage lineages (Ash, 1980) (Fig. 1). They are multi-nucleated cells that resorb bone. 
Osteoblasts regulate the differentiation of osteoclasts and osteocytes, which secrete factors 
in a feedback loop that play a role in regulating the functions of osteoblasts (Hartmann, 
2006) and osteoclasts (Seeman & Delmas, 2006). The formation and resorption of bone is a 
continuous process that is kept in balance by the regulation of these three types of cells, 
with emphasis on osteoblasts and osteoclasts. 
 
Fig. 1. Development of Bone Cells. Bone marrow stem cells give rise to hematopoietic stem 
cells and mesenchymal stem cells. Hematopoietic stem cells give rise to osteoclasts and 
mesenchymal stem cells are differentiated into osteoblasts together with other cell types. 
Osteoblasts further develop into bone lining cells and osteocytes.  
In some diseases this balance is disrupted, as in osteoporosis, where increased osteoclast 
activity results in more resorption of bone than formation by osteoblasts. Along with 
osteoporosis, other medical conditions like bone cancer and osteogenesis imperfecta can 
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lead to weakness of bones that can result in fractures. Bone defects can also occur due to 
trauma after accidents (Schäffler & Büchler, 2007). In addition, changes in recreational 
behavior especially in young adults lead to more need for bone replacement. Also, 
improved conditions of public health, nutrition and medicine have increased the life 
expectancy that resulted in an enhanced need for dental replacement. Taken together there 
is a growing need for bone regeneration and replacement. 
3. Bone regeneration and replacement 
3.1 The need for bone regeneration in dental defects 
Studies revealed that approximately 70 % of all adults between 35 and 44 years lost at least 
one permanent tooth and by the age of 74 around 26 % of the adults lost all their permanent 
teeth (National Institutes of Health, 2001). Additionally, 45 % of the adults between 35 and 
44 years and 54 % of the seniors between 65 and 74 years suffered from a middle heavy 
periodontitis, which is connected with a higher risk of tooth-loss (Holtfreter et al., 2010). To 
overcome these problems dental implants are one of the most common features to realize 
oral prosthetic reconstruction. 
In order to guarantee a long and successful osseointegration of dental implants, they should 
be circumferentially covered with bone. Furthermore, it seems advantageous that the 
intraosseous part of the fixture is longer than the extraosseous prosthetic part. At least, the 
length of the implant should not be shorter than the abutment. Nowadays correct implant 
placement is determined by esthetic and prosthetic aspects, which often cannot be realized 
when only the residually available bone (restoration-driven implant placement) is being 
used (Garber et al., 1995). (National Institutes of Health, 2001) 
There are defects of the alveolar bone which occur as a result of trauma, inflammation, 
resective surgical intervention such as tumor resection, bone loss after periodontal disease 
or athrophia after tooth loss or agenesis. In the posterior maxilla the phenomenon of 
pneumatization of the sinus maxillaris increases after tooth loss, which results in a vertical 
compromized bone level (Fig. 2A). Thus, bone reconstruction before or simultaneously to 
implant placement is often necessary (Fig. 2B). To do so guided, bone regeneration with 
autologous material such as bone graft material or other autologous or artificial grafting 
 
Fig. 2. A) Bone Degeneration. After tooth loss, reduced jawbone is as a result of trauma in a 
24 years old male. B) Pilot pins in situ demonstrate the compromized bone-situation (male, 
43 years old). Stable integration of implants is dependent on a thick jawbone. Stem cells 
could be used to fill the gaps and increase the thickness and induce osseointegration of 
implants. 
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procedures are methods of choice. Nevertheless, there exist many unsolved problems such 
as a e.g. higher morbidity in conjunction with the second wound of the donor site. 
Therefore the use of stem cells (SCs) as source material for bone regeneration could 
represent an interesting approach for dental implantology. 
3.2 Stem cells for bone regeneration 
A modern strategy in Regenerative Medicine is the approach to combine living cells and 
scaffold material to establish a biological alternative for the diseased organ or tissue that can 
restore the functions. (Sittinger et al., 1996; Vacanti & Langer, 1999; Khademhosseini et al., 
2009). Some degradable polymers, ceramics, or a combination of both can provide desirable 
mechanical and osteoconductive properties as basic scaffold material for bone replacement 
(Zippel et al., 2010b). Different factors should be considered for the use of such a biomaterial 
scaffold. It should imitate the three dimensional environment of the extracellular matrix, it 
should provide stability until replaced by regrown bone tissue and serve as an extended 
surface area for migration, adhesion, and differentiation of cells to encourage the growth of 
new tissue (Schultz et al., 2000; Ringe et al., 2002; Moroni et al., 2008). 
The proliferating cells cover the scaffold and can grow into three dimensional tissue within. 
They are also an important factor for forming new tissue through extracellular matrix 
synthesis (Bonassar & Vacanti, 1998). Due to the development of new blood vessels towards, 
and to some extent onto, the new tissue, the scaffold begins to degenerate from the outside and 
is reconstituted by new natural bone tissue. As tissue related cell types cannot always be 
obtained in an adequate number or quality, SCs are a useful alternative for tissue regeneration.  
Stem cells are the precursors of all cells and are involved in the repair system of the body. They 
are defined by three characteristics: self sustainability, self renewal and the potential of  
differentiation into different tissue types. For example adipocytes, astrocytes, chondroblasts, or 
osteoblasts come from mesenchymal stem cells (MSCs) (Pittenger et al., 1999; Pansky et al., 
2007). In several publications, it has been suggested that MSCs can differentiate towards 
lineages that are naturally derived from the endoderm (Zuk et al., 2002; Tobiasch, 2009).  Thus, 
increasing their potential because of these properties, the use of SCs to heal or rebuild damaged 
organs may provide an approach in future Regenerative Medicine (Zippel et al., 2010a). 
SCs have been isolated from embryonic sources and well developed tissues of adult organism 
such as bone marrow, skin, dental pulp and adipose tissue (Kern et al., 2006). In addition two 
other sources for SCs have been discovered: cancer stem cells and induced pluripotent stem 
cells (iPS) (Takahashi et al., 2007; Aoi et al., 2008).  Since the higher potency of embryonic stem 
cells and iPS compared to adult stem cells goes together with a higher risk of tumor formation, 
and embryonic stem cells are ethically problematic. Therefore, adult stem cells present 
themselves as an interesting cell source for bone replacement. 
Adult stem cells can be divided into two main subpopulations: hematopoietic and 
mesenchymal stem cells (MSCs). Hematopoietic stem cells derived from bone marrow have 
been investigated best and could be a source for osteoclasts (Ash, 1980) (see Fig. 1). MSCs 
have been found in umbilical cord blood, bone marrow, and adipose tissue among others 
(Zuk et al., 2002).  Generally, the isolation of MSCs is accomplished by plastic adherence 
resulting in colonies that are heterogeneous in size and morphology might contain 
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contaminating non-mesenchymal cells such as macrophages or fibroblasts. The purity of 
isolated MSCs can be investigated by using the surface markers: CD73, CD90, and CD105 
(should be expressed) and  CD14, CD34 and CD45 (should not be expressed). These markers 
serve next to the adherence to plastic as a second feature for the identification and 
characterization of MSCs as suggested by the ‘International Society for Cellular Therapy’ 
(Dominici et al., 2006). 
Another group of adult stem cells that has attracted attention are the ectomesenchymal stem 
cells derived from oral tissues. This stem cell group includes the dental pulp stem cells 
(DPSCs) and stem cells of human exfoliated deciduous teeth (SHEDs), both deriving from 
the pulpa, dental periodontal ligament stem cells (DPLSCs), dental follicle cells (DFCs), and 
stem cells from the apical papilla (SCAPs) (see Fig. 3). These cell types have the potential to 
differentiate into cells of all dental tissue types and bone as well. They share common 
phenotypic markers of MSCs (Alipur et al., 2010).  
 
Fig. 3. Stem Cell Types in Tooth. From tooth different stem cell types namely, dental pulp 
stem cells (DPSCs), stem cells of human exfoliated deciduous teeth (SHEDs), dental 
periodontal ligament stem cells (DPLSCs), dental enamel derived stem cells (DESCs), stem 
cells from the apical papilla (SCAPs) and dental follicle cells (DFCs) can be obtained. 
In comparison to other dental sources, dental follicle cells (DFCs) can be easily obtained in 
high amounts from young and healthy donors, since they are isolated from tooth extraction 
material collected during surgical removal of wisdom teeth. As these cells are derived from 
young donors, long telomeres extend their lifespan which makes them interesting cells for 
Regenerative Medicine (Shay & Wright, 2010). The dental follicle develops from 
ectomesenchyme. It surrounds the developing tooth germ before eruption (Ten Cate, 1997; 
Wise, 2002). During embryonic development, the ectomesenchyme is partly derived from 
migrating cells of the cranial neural crest. Therefore, the cells derivative from dental follicle 
differ from mesenchymal stem cells isolated from other sources (Chung et al., 2004; 
Slootweg, 2009). Due to having the more ectodermal character, these cells can have a 
differentiation potential diverse from MSCs. As expected these cells can differentiate into 
hard tissue such as the periodontal, cementoblastic, chondrocytic, and osteogenic lineages.  
ATSCs and DFCs, both show osteogenic differentiation potential and are thus suitable 
candidates for the use in bone regeneration for stable osseointegration of dental implants. 
As these cells are obtained from healthy individuals, they might be used as an autograft in 
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the future. The transplantation not only of autologous but also of allogenic sources could 
provide benefits in comparison to other common procedures in bone regeneration. As MSCs 
have low immune characteristics, they appear to be suitable for allogenic therapeutic 
purposes, without activating the immune response in immunocompetent patients (Jung et 
al., 2009). In different studies the use of MSCs has been investigated to replace lost or 
damaged bone (Schaefer et al., 2000; Ringe et al., 2002). After tooth loss, jawbone 
degenerates and stable integration of dental implant needs a thick jawbone. To overcome 
this problem there are two different alternatives that can be considered for using SCs in 
dental implants. The reconstruction after bone defects with SCs to achieve a sufficient bone 
thickness to insert the implants and the loading of an implant or artificial tooth-root with 
SCs with the aim to realize a sufficient integration in the bone. 
SCs have the capability to re-establish cell function, reverse cellular damage, and heal 
damaged tissue (Conrad and Huss, 2005). SCs could also be a source to regenerate human 
teeth in the future, as these cells have been successfully used to regenerate living teeth in rabbit 
extraction sockets (Hung et al., 2011). In some mammals like rodents, rabbits, prairie dogs, and 
pikas, the teeth can grow throughout life because in these mammals as the pulp cavity remains 
open permanently. While on the other hand in humans tooth cannot grow continuously as 
pulp cavity closes when the teeth are fully grown. Therefore this study cannot be adapted 
easily for the regeneration of teeth or teeth related tissues in humans but it at least provides 
interesting basic results that can be helpful for use of SCs in dental tissues. 
3.3 Bone chips for the stabilization of dental implants 
Another approach next to scaffold loaded with stem cells to overcome the problem of 
unstable dental implants is the use of particulated non-vascularized bone autografts. The 
particles can be collected during the implant-bed preparation in the process of drilling the 
hole for the implant into the bone. An advantage of the use of these bone chips is that this 
material can be expected to facilitate bone regeneration. However, contradictory statements 
were made about the quality of this material such as if it contains living cells. In addition, it 
is not clear how to disinfect the bone chips, which are contaminated with bacteria of the oral 
cavity due to the sampling process. To address these questions bone chips were collected 
from two different regions of bone: carticular bone and spongy bone (see Fig. 4). 
 
Fig. 4. Schematic Structure of Lower Jaw. Bone is composed of two tissue types mainly: 
spongious and carticular bone. Bone chips obtained during dental surgery for implant-bed 
preparation is derived from both bone tissue types. 
spongy 
bone 
carticular bone 
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4. Research methods  
4.1 Isolation of primary cells for osteo-differentiation 
4.1.1 Isolation of cells from tooth extraction material 
For the isolation of ectomesenchymal stem cells, dental follicles were collected from human 
third molars before tooth eruption after surgical removal. The dental follicles were washed 
three times with 1 x PBS. Afterwards, the dental follicles were separated from the 
mineralized tooth and minced with a scalpel under sterile conditions. The tissue was 
digested in Collagenase (0.1 U / mL) and Dispase (0.8 U / mL) for 2 h at 37 °C in humidified 
atmosphere with 5 % CO2. The cells were passed through a 100 µm strainer to obtain single-
cell suspensions and seeded in 10 cm dishes in stem cell medium (SCM) that consisted of 
DMEM supplemented with 10 % FCS, 2 mM L-glutamine, 100 units / mL penicillin, 100 mg 
/ mL streptomycin and 1 % amphotericin and cultured at 37 °C in a humidified atmosphere 
with 5 % CO2. After 24 hours, non-adherent cells were removed by washing with 1 x PBS.  
The medium was changed and the plastic adherent cell fraction was cultured until 80 % 
confluent for further use. 
The bone chip particles were collected with a bone filter integrated into a surgical suction 
pipe during the implant-bed preparation to isolate primary cells. For the isolation of bone 
chip derived cells (BCDCs), the same procedure as described above for DFCs was 
followed. 
4.1.2 Isolation of adipose tissue derived stem cells 
Human adipose tissue derived stem cells (ATSCs) were isolated from lipoaspirate obtained 
from plastic surgery. The isolation technique used during surgery was the tumescent 
liposuction technique. Using this particular technique, diluted epinephrine and lidocaine is 
infiltrated into the body fat to be removed, which leads to swelling and firmness of the 
targeted region, providing more accuracy during the liposuction procedure. The protocol 
was adjusted and modified to the procedure described by Zuk and colleagues (Zuk et al., 
2001). The obtained lipoaspirate was augmented with PBS in a 1:2 ratio. After incubation for 
30 minutes at room temperature (RT), two phases, a lower aqueous and upper fat phase of 
the lipoaspirate were obtained. 
The lower phase was centrifuged at 200 x g for 10 minutes at RT. The resulting pellets, 
comprising the cells, were pooled and washed with 1 x PBS. Remaining erythrocytes were 
removed by applying 10 mL erythrolysis buffer for 10 minutes at RT. After another 
centrifugation step, under the same conditions as mentioned before, the cells were cultured 
in 60 cm2 culture plates in SCM medium. 
The upper phase comprising the fat tissue was augmented with 10 mg / mL type I 
collagenase in 1 x PBS and incubated for 45 minutes at 37 °C with agitation. The following 
steps for the treatment of the upper phase were according to the treatment of the lower 
phase. Cells of both phases were incubated at 37 °C with 5 % CO2 in a humidified 
atmosphere. ATSCs were isolated due to their adherence to plastic and purified by washing 
with 1 x PBS after 24 hours, to remove undesired non-adherent cells. 
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4.2 Fluorescence activated cell sorting 
The percentages of ATSCs or DFCs positive for the mesenchymal stem cell markers CD44, 
CD90 and CD105 and negative for CD14, CD45 and CD34 were measured using FACS 
analysis. The stem cells were trypsinized, centrifuged at 200 x g for 5 min and counted. 1 x 
106 cells were resuspended in 1 mL 0.1 % PBSB and passed through a 100 μM cell strainer to 
obtain a single cell solution. 100 μL of the cell solution (100.000 cells) were incubated for 20 
min in the dark with either the isotype control or the antibodies. Cells were washed with 2 
mL 0.1 % (w / v) PBSB, centrifuged at 200 x g for 5 min and resuspended in 1 mL 0.1 % (w / 
v) PBSB. The cytometer settings and cell gates were adjusted to the isotype control, followed 
by measurement of the stem cell markers using the same conditions. 
4.3 Adipogenic differentiation 
For adipogenic induction, the isolated cells were seeded in a density of 2.8 x 103 cells / cm2 
in SCM. After one day, the medium was changed to adipogenic differentiation medium 
(AM), containing 1 μM dexamethasone, 1 μM insulin and 200 μM indomethacin. The cells 
were grown in AM for four weeks at 37 °C with 5 % CO2 under humidified conditions. The 
AM was changed once a week. After four weeks, adipogenic differentiation was visualized 
with Oil Red O after fixing cells for 90 min with formalin (4 %) at 37 °C. 
4.4 Osteogenic differentiation 
The isolated cells were seeded in a density of 1.3 x 103 cells / cm2 in 6 cm2 and 12 well plates 
for osteogenic differentiation. After one day SCM was replaced with osteogenic medium 
(OM) containing dexamethasone, ascorbic acid and ǃ-glycerophosphate. ATSCs were grown 
in OM for 4 weeks at 37 °C with 5 % CO2 under humidified conditions. The OM medium 
was changed once a week. After four weeks, osteogenic differentiation was visualized by 
staining with Alizarin Red S after fixing cells for 5 min with formalin (4 %) at 37 °C. 
4.5 Microbiological testing 
Directly after surgery the obtained dental follicles were transferred into cold sodium 
chloride (0.9 % w / v) for determining possible microbial contaminations. The samples were 
kept cold until processing. 
The samples were rolled over the surface of Columbia blood agar (CBA) and fastidious 
anaerobe agar (FAA) plates to isolate microorganisms. In addition the transport solution 
was put onto CBA and FAA plates. Under aerobic and anaerobic conditions the incubations 
were conducted over night at 37 °C. The Gas PakTM100-system was used for the incubation 
under anaerobic conditions. Single colonies were picked and isolated with respect to their 
morphological differences. Gram stainings, catalase- and oxidase-tests were used for the 
first characterization. API test strips were used to determine the exact bacteria species. 
5. Comparison of stem cell sources 
5.1 The characterization of ATSCs, DFCs and BCDCs for bone regeneration 
The high plasticity of mesenchymal stem cells has resulted in an increased interest for 
their use in a variety of cellular therapies. However, different laboratories working with 
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these cells isolate them from various tissue sources by following different protocols and 
characterizing these cells by different markers. Therefore, to set a standard, the minimal 
criteria for the definition of human MSCs were suggested by the ‘Mesenchymal and 
Tissue Stem Cell Committee of The International Society for Cellular Therapy’ (Dominici 
et al., 2006). The multipotent character of the isolated adipose tissue derived stem cells, 
ectomesenchymal dental follicle cells and bone chip derived cells was tested according to 
these criteria. MSCs were isolated from human adult adipose tissue of different aged 
female donors. DFCs were isolated from dental follicles and BCDCs from the bone chips 
collected during implant-bed preparation of male and female donors. The enrichment of 
specific stem cells was achieved due to their property of plastic adherence that is the first 
criterion for the testing of aMSCs character (Dominici et al., 2006). Isolated mesenchymal 
and ectomesenchymal cells of all donors showed a morphology similar to fibroblasts, 
which is typical for these stem cells (Yoshimura et al., 2006). 
According to the above mentioned criteria the isolated cells should express the stem cell 
specific surface markers CD73, CD90, and CD105, and should not express CD14, CD34, and 
CD45. All isolated SC types expressed the expected markers (CD73, CD90 and CD105) as 
assessed by RT-PCR. The mesenchymal character of ATSCs and DFCs was also confirmed 
using FACS analysis for the presence of CD90, CD105, and in addition CD44. Furthermore, 
the cell types ATSCs and DFCs did not show the expression of leukocyte marker CD45 and 
macrophage marker CD14. ATSCs were positive and DFCs were negative for CD34. The 
presence of the expression of CD34 on ATSCs is controversial discussed. Some studies 
confirm the absence of CD34 expression on ATSCs (Zuk et al., 2002; Lee et al., 2004; Wagner 
et al., 2005) while other investigations showed ATSCs expressing CD34 (Mitchell et al., 2006; 
Yoshimura et al., 2006; De Francesco et al., 2009). These differences could be due to different 
stem cell isolation protocols, passage number or a different gating strategy during FACS 
analysis. In this study a subpopulation of ATSCs was stained positive for CD34. 
Another typical MSCs character is the multilineage differentiation potential towards various 
lineages such as adipocytes, chondroblasts and osteoblasts. ATSCs showed a strong 
adipogenic differentiation potential whereas DFCs and BCDCs could not differentiate 
towards adipocytes. However, Kémoun and colleagues reported DFCs to differentiate 
towards the adipogenic lineage (Kémoun et al., 2007). The differences during isolation and 
precipitation in cell population might be possible reasons for this discrepancy. Also, DFCs 
can be different in their potency because these cells are derived from ectomesenchyme that 
is more committed toward hard tissue as tooth enamel. 
According to all the findings mentioned above, the isolated ATSCs can be considered to 
belong to the population of multipotent MSCs, whereas the DFCs and BCDCs have a limited 
differentiation potential. Haddouti and colleagues showed that DFCs have a strong 
commitment towards the osteogenic lineage and show a more quantitative osteogenic 
differentiation (Haddouti et al., 2009). Thus, DFCs and BCDCs seem to be more committed 
towards osteogenic lineage. 
Taken together all these stem cell types are good candidates for bone regeneration. But 
material from the oral cavity for isolation of primary cells such as DFCs and BCDCs cannot 
be obtained without microbial contamination. The question arises if this is a draw back on 
the use of these stem cells. 
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5.2 Microbial load of the oral tissue material 
In order to evaluate the quality of the cells derived from oral tissues, microbiological 
investigations were performed. Our results revealed that all samples contained microbial 
species. Pre-treatment of patients with the antibiotics chlorhexidine (0.2 %), which is done 
anyway to decrease the chances of inflammation after surgery, reduced the number of 
microorganisms to less than 5 % but did not suffice to eliminate all bacteria. On the other 
hand pre-surgical, antibiotic treatment seemed to be negative for cell-outgrowth. To reduce 
contamination of the harvested cell-material, an optimized surgical procedure is more 
important than pre-surgical irrigation with chlorhexidine (0.2 %), and the use of a stringent 
dual suction pipe procedure. The predominantly found species were gram-positive cocci 
being either catalase-positive and oxidase-negative or catalase- and oxidase-negative. Most 
microorganisms belonged to the families of Streptococcaceae and Staphylococcaceae. The 
detected microorganisms did not interfere with cell growth and differentiation. They can be 
easily suppressed with standard antibiotics, applied routinely in patient treatment during 
the implantation procedure. Thus, these stem cells can be used for bone regeneration in 
dental implants. 
6. Conclusion 
The stability of dental implants is associated with a successful osseointegration into thick 
jawbone. Due to bone defects, bone regeneration is often needed before an implant can be 
inserted. For this stem cells can be a suitable candidates. 
The stem cells isolated from adipose tissue, dental follicle and bone chips share mainly the 
multipotent character of mesenchymal stem cells. ATSCs can be successfully differentiated 
towards adipogenic and osteogenic lineages while DFCs and BCDCs did not show 
adipogenic differentiation. However, these cell types showed stronger commitment and 
differentiation towards osteogenic lineage. Therefore all three cell types are promising 
candidates for the treatment of various bone defects, and therefore also for the incorporation 
of tooth implants. They can be used to reconstruct jawbone defects to achieve enough bone 
thickness for the insertion of dental implants. It might be possible to load these cells on a 
dental implant or an artificial tooth root to increase its integration stability with the bone.  
DFCs might be an ideal option if there will be a bank of donor material for these cells in the 
future, similar to those banks already existing as umbilical cord blood stem cells. If DFCs 
and BCDCs are not available for a specific patient, ATSCs are a reasonable option as they 
can differentiate towards the osteogenic lineage and be obtained from the patient itself as 
well, reducing the risk for rejection. Taken together all these tested stem cell types are 
suitable to improve the conditions for dental implants. Patients could preserve their dental 
follicle cells for later use in the future or their stem cells could be isolated from fat tissue 
directly before use. If a stem cell bank is arranged in the future, stem cells from other stem 
cell donors for dental follicle and fat tissue derived SCs could be used. 
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8. List of abbreviation 
ALP Alkaline phosphatase
AM Adipogenic medium
ATSCs Human adipose tissue derived mesenchymal stem cells
BCDCs Bone chip derived cells
BMP2 Bone morphogenetic protien 2
°C Degree centigrade
CBA Columbia blood agar
CD14 Cluster of differentiation 14
CD34 Cluster of differentiation 34
CD45 Cluster of differentiation 45
CD73 Cluster of differentiation 73
CD90 Cluster of differentiation 90
CD105 Cluster of differentiation 105 
cm Centimeter
CO2 Carbon dioxide
DESCs Dental enamel derived stem cells
DFCs Dental follicle cells
DMEM Dulbecco’s modified Eagle medium
DPLSCs Dental periodontal ligament stem cells
DPSCs Dental pulp stem cells
ECSs Embryonic stem cells
FAA Fastidious anaerobe agar
FACs Fluorescence activated cell sorting
FCS Fetal calf serum
iPS Induced pluripotent stem cells
IGF-1 Insulin-like growth factor 1
LPL Lipoprotein lipase
mL Milliliter
mM Millimolar
µL Microliter
OM Osteogenic medium
PBS Phosphate buffer saline
PPARǄ Peroxisome proliferator-activated receptor gamma
RT Room temperature
RT-PCR Reverse transcriptase polymerase chain reaction
Runx2 Runt-related transcription factor 2
SCAPs Stem cells from the apical papilla
SCM Stem cell medium
SCs Stem cells
SHEDs Stem cells of human exfoliated deciduous teeth
w / v Weight per volume
x g Relative centrifugal force
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